Login to Your Account

Pharma Two B lands $30M in C round, adds Jeff Kindler to board

By Cormac Sheridan
Staff Writer

Monday, February 27, 2017

DUBLIN – Pharma Two B Ltd., a privately held specialty pharma firm, closed its third round of funding at $30 million in order to complete clinical development and registration of its lead program, P2B001, a combination therapy for Parkinson's disease, and to add additional products to its portfolio.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription